Related Experiment Video
Updated: Jul 13, 2026

Mapping Infant Immunity with Minimal Input: Integrative Single-Cell and Multiomic Profiling
Published on: April 3, 2026
[Epidemiologic profile of very low birth weight infants treated with red blood cell transfusions]
Joaquín Darío Treviño-Báez1, Ricardo Jorge Hernández-Herrera
1Pediatra del Departamento de Neonatología, Unidad Médica de Alta Especialidad 23 Dr Ignacio Morones Prieto, Instituto Mexicano del Seguro Social, Monerrey, Nuevo León, Mexico. joaquindtb@yahoo.com.mx
Insights
Most very low birth weight (VLBW) infants receive red blood cell (RBC) transfusions, posing risks. This study profiles VLBW infants receiving transfusions, suggesting restrictive guidelines and single-donor programs may be beneficial.
Area of Science:
- Neonatal Medicine
- Hematology
- Pediatrics
Context:
- Neonatal period sees high rates of red blood cell (RBC) transfusions in very low birth weight (VLBW) infants (birth weight < 1500 g).
- These transfusions carry significant infectious, biochemical, immunologic, and oxidative risks.
- Understanding the epidemiological profile of transfused VLBW infants is crucial for risk mitigation.
Purpose:
- To describe the epidemiological profile of very low birth weight infants who undergo red blood cell transfusions.
- To analyze the characteristics of transfusion events in this vulnerable population.
Summary:
- A retrospective review of 61 VLBW newborns in Monterrey, México, found a 70.5% transfusion prevalence.
- Transfusions occurred predominantly in the early postnatal period, with an average of two transfusions per infant.
- Infants on mechanical ventilation with high oxygen requirements were frequently transfused.
Impact:
- The epidemiological profile aligns with international reports, validating the findings.
- Transfusion characteristics suggest potential benefits from implementing restrictive transfusion guidelines.
- The study highlights the possibility of evaluating single-donor blood programs to reduce transfusion risks in VLBW infants.
Introduction:
during the neonatal period seventy to ninety percent of very low birth weight (VLBW) infants (birth weight < 1500 g), are transfused with red blood cells (RBC) at least once; that represents infectious, biochemical, immunologic and oxidative risks. The objective of this paper is to describe the epidemiological profile of the VLBW infants that are transfused with RBC.
Methodology:
a retrospective review of 61 VLBW newborns admitted to the Neonatology Unit of a tertiary care hospital in Monterrey, México was conducted. The sample was collected consecutively. The information included the newborns epidemiological profile and the characteristics of transfusion events.
Results:
the prevalence of transfused newborns was 70.5%, 82 transfusions were in the early postnatal period (<28 days) and 32 in the late postnatal period (> or = 28 days); 43.9% of newborns had mechanical ventilation and their fraction of inspired oxygen was > or = 0.3. Mean birth weight and standard deviation of VLBW newborns were 1206 +/- 198 g; the hematocrit before transfusion was 33.63 +/- 4.17 mg/dL, and the RBC volume per transfusion was 16.85 +/- 4.85 mL. On average, the newborns had two donors and two transfusions.
Conclusions:
the epidemiological profile of the newborns included in this analysis was similar to published international reports. The transfusion characteristics suggest the possibility to apply restrictive guidelines and to evaluate a single-donor blood program for these newborns.
Related Concept Videos
Rh Blood Group
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...